LIVEPERSON INC (LPSN) Fundamental Analysis & Valuation

NASDAQ:LPSN • US5381463091

3.21 USD
-0.16 (-4.75%)
Last: Mar 6, 2026, 08:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This LPSN fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

1

Overall LPSN gets a fundamental rating of 1 out of 10. We evaluated LPSN against 276 industry peers in the Software industry. Both the profitability and financial health of LPSN have multiple concerns. LPSN does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

1

1. LPSN Profitability Analysis

1.1 Basic Checks

  • In the past year LPSN has reported negative net income.
  • In the past year LPSN has reported a negative cash flow from operations.
  • In the past 5 years LPSN always reported negative net income.
  • The reported operating cash flow has been mixed in the past 5 years: LPSN reported negative operating cash flow in multiple years.
LPSN Yearly Net Income VS EBIT VS OCF VS FCFLPSN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50M -100M -150M -200M

1.2 Ratios

  • LPSN's Return On Assets of -26.06% is on the low side compared to the rest of the industry. LPSN is outperformed by 76.81% of its industry peers.
Industry RankSector Rank
ROA -26.06%
ROE N/A
ROIC N/A
ROA(3y)-18.28%
ROA(5y)-15.21%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
LPSN Yearly ROA, ROE, ROICLPSN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 -200 -300

1.3 Margins

  • Looking at the Gross Margin, with a value of 72.19%, LPSN is in line with its industry, outperforming 57.25% of the companies in the same industry.
  • LPSN's Gross Margin has been stable in the last couple of years.
  • The Profit Margin and Operating Margin are not available for LPSN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 72.19%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.73%
GM growth 5Y-0.79%
LPSN Yearly Profit, Operating, Gross MarginsLPSN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. LPSN Health Analysis

2.1 Basic Checks

  • LPSN does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • LPSN has more shares outstanding than it did 1 year ago.
  • LPSN has more shares outstanding than it did 5 years ago.
  • LPSN has a worse debt/assets ratio than last year.
LPSN Yearly Shares OutstandingLPSN Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M
LPSN Yearly Total Debt VS Total AssetsLPSN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

  • LPSN has an Altman-Z score of -2.37. This is a bad value and indicates that LPSN is not financially healthy and even has some risk of bankruptcy.
  • LPSN's Altman-Z score of -2.37 is on the low side compared to the rest of the industry. LPSN is outperformed by 78.26% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -2.37
ROIC/WACCN/A
WACC1.5%
LPSN Yearly LT Debt VS Equity VS FCFLPSN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

  • LPSN has a Current Ratio of 1.18. This is a normal value and indicates that LPSN is financially healthy and should not expect problems in meeting its short term obligations.
  • With a Current ratio value of 1.18, LPSN is not doing good in the industry: 67.75% of the companies in the same industry are doing better.
  • LPSN has a Quick Ratio of 1.18. This is a normal value and indicates that LPSN is financially healthy and should not expect problems in meeting its short term obligations.
  • With a Quick ratio value of 1.18, LPSN is not doing good in the industry: 67.03% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.18
Quick Ratio 1.18
LPSN Yearly Current Assets VS Current LiabilitesLPSN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

2

3. LPSN Growth Analysis

3.1 Past

  • LPSN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -132.46%.
  • Looking at the last year, LPSN shows a very negative growth in Revenue. The Revenue has decreased by -23.03% in the last year.
  • Measured over the past years, LPSN shows a small growth in Revenue. The Revenue has been growing by 1.39% on average per year.
EPS 1Y (TTM)-132.46%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%44.79%
Revenue 1Y (TTM)-23.03%
Revenue growth 3Y-12.7%
Revenue growth 5Y1.39%
Sales Q2Q%-18.98%

3.2 Future

  • The Earnings Per Share is expected to grow by 27.30% on average over the next years. This is a very strong growth
  • The Revenue is expected to decrease by -17.02% on average over the next years. This is quite bad
EPS Next Y75.3%
EPS Next 2Y27.3%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-22.96%
Revenue Next 2Y-17.02%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
LPSN Yearly Revenue VS EstimatesLPSN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 100M 200M 300M 400M 500M
LPSN Yearly EPS VS EstimatesLPSN Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 -10 -20 -30 -40

More info and screens

Find the best growth stocksShow best growing peers

1

4. LPSN Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for LPSN. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for LPSN. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
LPSN Price Earnings VS Forward Price EarningsLPSN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
LPSN Per share dataLPSN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 20 -20

4.3 Compensation for Growth

  • A more expensive valuation may be justified as LPSN's earnings are expected to grow with 27.30% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y27.3%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. LPSN Dividend Analysis

5.1 Amount

  • LPSN does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

LPSN Fundamentals: All Metrics, Ratios and Statistics

LIVEPERSON INC

NASDAQ:LPSN (3/6/2026, 8:00:00 PM)

3.21

-0.16 (-4.75%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)03-03
Earnings (Next)05-05
Inst Owners24.4%
Inst Owner Change-75.83%
Ins Owners2.89%
Ins Owner Change21.79%
Market Cap38.07M
Revenue(TTM)257.66M
Net Income(TTM)-133.26M
Analysts47.5
Price Target11.73 (265.42%)
Short Float %9.24%
Short Ratio5.57
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)30.05%
Min EPS beat(2)21.27%
Max EPS beat(2)38.84%
EPS beat(4)3
Avg EPS beat(4)-90.35%
Min EPS beat(4)-460.85%
Max EPS beat(4)39.36%
EPS beat(8)4
Avg EPS beat(8)-18.64%
EPS beat(12)6
Avg EPS beat(12)-29.79%
EPS beat(16)9
Avg EPS beat(16)-9.7%
Revenue beat(2)1
Avg Revenue beat(2)1.51%
Min Revenue beat(2)-0.24%
Max Revenue beat(2)3.26%
Revenue beat(4)2
Avg Revenue beat(4)1.76%
Min Revenue beat(4)-1.28%
Max Revenue beat(4)5.3%
Revenue beat(8)5
Avg Revenue beat(8)1.69%
Revenue beat(12)6
Avg Revenue beat(12)0.47%
Revenue beat(16)8
Avg Revenue beat(16)0.27%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)-8.74%
EPS NQ rev (3m)7.31%
EPS NY rev (1m)0%
EPS NY rev (3m)43.43%
Revenue NQ rev (1m)-0.12%
Revenue NQ rev (3m)-2.75%
Revenue NY rev (1m)0.35%
Revenue NY rev (3m)0.21%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.15
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-26.5
EYN/A
EPS(NY)-8.82
Fwd EYN/A
FCF(TTM)-3.36
FCFYN/A
OCF(TTM)-2.01
OCFYN/A
SpS21.73
BVpS-0.12
TBVpS-22.82
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -26.06%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 72.19%
FCFM N/A
ROA(3y)-18.28%
ROA(5y)-15.21%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.73%
GM growth 5Y-0.79%
F-Score4
Asset Turnover0.5
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 64.39%
Cap/Sales 6.18%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.18
Quick Ratio 1.18
Altman-Z -2.37
F-Score4
WACC1.5%
ROIC/WACCN/A
Cap/Depr(3y)73.49%
Cap/Depr(5y)106.31%
Cap/Sales(3y)9.03%
Cap/Sales(5y)9.85%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-132.46%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%44.79%
EPS Next Y75.3%
EPS Next 2Y27.3%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-23.03%
Revenue growth 3Y-12.7%
Revenue growth 5Y1.39%
Sales Q2Q%-18.98%
Revenue Next Year-22.96%
Revenue Next 2Y-17.02%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y63.45%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year129.97%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y15.58%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-244.82%
OCF growth 3YN/A
OCF growth 5YN/A

LIVEPERSON INC / LPSN FAQ

Can you provide the ChartMill fundamental rating for LIVEPERSON INC?

ChartMill assigns a fundamental rating of 1 / 10 to LPSN.


What is the valuation status for LPSN stock?

ChartMill assigns a valuation rating of 1 / 10 to LIVEPERSON INC (LPSN). This can be considered as Overvalued.


How profitable is LIVEPERSON INC (LPSN) stock?

LIVEPERSON INC (LPSN) has a profitability rating of 1 / 10.


Can you provide the expected EPS growth for LPSN stock?

The Earnings per Share (EPS) of LIVEPERSON INC (LPSN) is expected to grow by 75.3% in the next year.